Join our IMID Observatory for immune medicated inflammatory diseases

Use real-world data (RWD) to monitor treatment pathways of patients with conditions in this field to evaluate the standard of care, clinical effectiveness and associated costs of different treatment paths.

Untitled (600 x 400 px) (7)

Gain unique international insights

Understand the patient pathways of IMID patients across Europe in terms of  diagnostics, treatments and outcomes. Discover best practices and optimise the quality of care and healthcare resource utilisation (HCRU).

Actionable insights into drug use and effectiveness 

Gain insights into the uptake of a specific drug, the use of a specific drug in patient pathways, and the effectiveness of the drug in a standardised manner​.
IMID Observatory 1

Hospitals participate burden free

We run treatment improvement projects that are easy to join. They are, by design, completely compliant with all legal requirements around ethics, data security, and privacy.

IMID Observatory 2

Unlocking the value of RWD

By enabling the use of real-world data that reflect the actual population treated, it is possible to assess treatment effects. This makes timely decision-making easy and evidence-driven.
Solid Cancer Observatory 2

What makes our Observatory approach unique?

Frequently Asked Questions

What is the legal basis for processing data in the Observatories?

The legal basis for processing data in our projects is provided by GDPR article 9.2(h), which covers projects designed to improve "the management of health or social care systems and services."

Who is responsible for data management, and how is it structured?

The hospital is the data controller, while LOGEX acts as the data processor, ensuring data is handled according to the legal and ethical guidelines.

Are there any specific requirements or ethical approvals needed for the Observatories?

Ethical approval might be necessary in specific cases and is dependent on local guidance and regulations. The focus of the observatory is to improve healthcare and outcomes for participating hospitals, which means ethical approval is not required in certain countries or specific situations.

How is hospital data handled and are there any restrictions on sharing it?

Hospitals remain the owners of their data at all times. Only anonymous population data may be shared with third parties, and LOGEX strictly follows local regulations regarding cross-border data transfers.

Back to top

Get more out of our Healthcare Intelligence

Go beyond Real-World Data with Patient Engagement and Financial Analytics.

Secure, compliant and trusted.

Healthcare organisations worldwide trust LOGEX.

Breaking Barriers in International Psoriasis Research Through Data Standardisation

Discover how LOGEX is transforming international psoriasis research through innovative data standardisation, enabling faster, more reliable insights across Europe. 

Actionable insights into innovative medicines and their costs

Report: "On the Horizon".

March 2024 edition. 

Download now Contact us
Placeholder media

Learn how to leverage data
to make better decisions.

Read our latest publications about how we support data-driven decision-making.

Get clarity and control to make better decisions.

Do you have any questions about harnessing data-driven insights for better decision-making? Allow our experts, such as Sarah, to lead the way.

We will reply within two business days.

Speak to an expert Request a demo
_DSF3228-1